Product Information
ARICEPT 10 MG TABLET is a brand product labeled by Eisai Inc., priced at $16.1969 per EA under NDC 62856024630. Its NADAC has been published 308 times since Nov 28, 2013.
FDA first approved this application on Nov 25, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the donepezil hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Eisai Inc.NDC
62856024630
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020690FDA Approved
11/25/1996
TE Code
AB
On Market Since
11/25/1996
Pharmacological Classes
Price Statistics
The NADAC for ARICEPT 10 MG TABLET has been published 308 times since Nov 28, 2013, and over the history we have for it it has risen 40.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.1969 per EA |
|---|---|
| All-time high | $16.5867 (Feb 10, 2016) |
| All-time low | $11.5318 (Nov 28, 2013) |
| 52-week high | $16.1969 |
| 52-week low | $16.1969 |
| Median price | $16.1333 |
| Average price | $15.3492 |
| Largest weekly change | +10.0% (Oct 8, 2014) |
| Weeks tracked | 308 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+0.4%
5Y
+0.4%
All
+40.5%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eisai Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
donepezil hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARICEPT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARICEPT 10 MG TABLET, manufactured by Eisai Inc., is $16.1969 per EA (NDC 62856024630), effective Feb 11, 2026.
How has the price of ARICEPT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARICEPT 10 MG TABLET has risen 40.5%. It has been tracked across 308 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ARICEPT 10 MG TABLET?
Since Nov 28, 2013, the NADAC for ARICEPT 10 MG TABLET has ranged from a low of $11.5318 (Nov 28, 2013) to a high of $16.5867 (Feb 10, 2016), with a median of $16.1333 per EA.
Are there cheaper alternatives to ARICEPT 10 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DONEPEZIL HCL 10 MG TABLET, is $0.0484 per EA — about 99% below ARICEPT 10 MG TABLET.
Who manufactures ARICEPT 10 MG TABLET?
ARICEPT 10 MG TABLET (NDC 62856024630) is labeled by Eisai Inc., and CMS classifies it as a brand product.